- Home
- CARV vs AYTU Comparison
CARV vs AYTU Comparison
Compare CARV & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARV
- AYTU
- Stock Information
- Founded
- CARV 1948
- AYTU N/A
- Country
- CARV United States
- AYTU United States
- Employees
- CARV N/A
- AYTU N/A
- Industry
- CARV Savings Institutions
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- CARV Finance
- AYTU Health Care
- Exchange
- CARV Nasdaq
- AYTU Nasdaq
- Market Cap
- CARV 7.3M
- AYTU 8.3M
- IPO Year
- CARV 1994
- AYTU N/A
- Fundamental
- Price
- CARV $1.51
- AYTU $1.78
- Analyst Decision
- CARV
- AYTU
- Analyst Count
- CARV 0
- AYTU 0
- Target Price
- CARV N/A
- AYTU N/A
- AVG Volume (30 Days)
- CARV 21.8K
- AYTU 3.7M
- Earning Date
- CARV 07-15-2025
- AYTU 05-14-2025
- Dividend Yield
- CARV N/A
- AYTU N/A
- EPS Growth
- CARV N/A
- AYTU N/A
- EPS
- CARV N/A
- AYTU N/A
- Revenue
- CARV $24,056,000.00
- AYTU $77,691,000.00
- Revenue This Year
- CARV N/A
- AYTU N/A
- Revenue Next Year
- CARV N/A
- AYTU $8.14
- P/E Ratio
- CARV N/A
- AYTU $6.70
- Revenue Growth
- CARV N/A
- AYTU N/A
- 52 Week Low
- CARV $1.30
- AYTU $0.95
- 52 Week High
- CARV $2.39
- AYTU $3.23
- Technical
- Relative Strength Index (RSI)
- CARV 57.40
- AYTU 55.38
- Support Level
- CARV $1.35
- AYTU $1.90
- Resistance Level
- CARV $1.52
- AYTU $2.70
- Average True Range (ATR)
- CARV 0.09
- AYTU 0.20
- MACD
- CARV 0.01
- AYTU -0.01
- Stochastic Oscillator
- CARV 84.00
- AYTU 37.84
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.